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Abstract
Background: As of 2016, almost 16 million individuals were cancer survivors, including over 3.5 million survivors of breast
cancer. Because cancer survivors are living longer and have unique health care needs, the Institute of Medicine proposed a survivor
care plan as a way to alleviate the many medical, emotional, and care coordination problems of survivors.
Objective: This pilot study for breast cancer survivors was undertaken to: (1) examine self-reported changes in knowledge,
confidence, and activation from before receipt to after receipt of a survivor care plan; and (2) describe survivor preferences for,
and satisfaction with, a technology-based survivor care plan.
Methods: A single group pretest-posttest design was used to study breast cancer survivors in an academic cancer center and a
community cancer center during their medical visit after they completed chemotherapy. The intervention was a technology-based
survivor care plan. Measures were taken before, immediately after, and 1 month after receipt of the survivor care plan.
Results: A total of 38 breast cancer survivors agreed to participate in the study. Compared to baseline levels before receipt of
the survivor care plan, participants reported increased knowledge both immediately after its receipt at the academic center (P<.001)
and the community center (P<.001) as well as one month later at the academic center (P=.002) and the community center (P<.001).
Participants also reported increased confidence immediately following receipt of the survivor care plan at the academic center
(P=.63) and the community center (P=.003) and one month later at both the academic center (P=.63) and the community center
(P<.001). Activation was increased from baseline to post-survivor care plan at both the academic center (P=.05) and community
center (P<.001) as well as from baseline to 1-month follow-up at the academic center (P=.56) and the community center (P<.001).
Overall, community center participants had lower knowledge, confidence, and activation at baseline compared with academic
center participants. Overall, 22/38 (58%) participants chose the fully functional electronic survivor care plan. However, 12/23
(52%) in the community center group chose the paper version compared to 4/15 (27%) in the academic center group. Satisfaction
with the format (38/38 participants) and the content (37/38 participants) of the survivor care plan was high for both groups.
Conclusions: This study provides evidence that knowledge, confidence, and activation of survivors were associated with
implementation of the survivor care plan. This research agrees with previous research showing that cancer survivors found the
technology-based survivor care plan to be acceptable. More research is needed to determine the optimal approach to survivor
care planning to ensure that all cancer survivors can benefit from it.
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Introduction
As of 2016, almost 16 million individuals were cancer survivors,
including over 3.5 million survivors of breast cancer [1].
Because cancer survivors are living longer and have unique
health care needs, the Institute of Medicine proposed a survivor
care plan to alleviate the many medical, emotional, and care
coordination problems of survivors [2,3]. Implementation of
the survivor care plan is resource-intensive, requiring time and
personnel to create and communicate the plan to survivors and
other stakeholders [4,5]. Given the many time demands on
health care providers, it is imperative to document the benefits
of the survivor care plan to survivors. However, several
randomized controlled trials have failed to show the benefits of
the survivor care plan in relieving survivor distress, improving
satisfaction with care, or improving care coordination [6-8].
A small body of research has not demonstrated the efficacy of
the survivor care plan (both paper and electronic documents)
in influencing survivor-reported outcomes. Three randomized
controlled trials of a survivor care plan paper document and
in-person session showed no effect on: cancer-specific or general
psychological distress, health-related quality of life, satisfaction,
or continuity of care [6], cancer worries, depression, or impact
of cancer [7], or the helpfulness of the materials [8]. A
technology-generated survivor care plan delivered after surgery
and updated during follow-up visits showed a difference in the
amount of information received (in favor of the survivor care
plan group) but no difference in satisfaction with the information
or care [9]. The survivor care plan group also reported more
symptoms, expressed more illness concerns, more emotional
upset, and reported more contact with their primary care
physician.
While it is possible that survivors derive limited benefit from
the survivor care plan, an alternative possibility is that other
patient-reported outcomes, such as knowledge or confidence,
could be better indicators of efficacy. Correlational studies have
shown a link between receipt of a survivor care plan and
increased knowledge and confidence of survivors [9-12]. Further
evidence has been provided by a small randomized trial (N=79)
about survivor transition coaching compared to usual care,
which showed a trend for higher self-efficacy (an indicator of
confidence) in the coaching group [13]. Another small
randomized trial comparing two survivor care plan interventions
showed increased confidence in both groups [14]. In a
single-group study, perceived knowledge increased after the
survivor care plan visit [15]. This evidence suggests that
knowledge and confidence should be evaluated further as
outcomes by which the benefit of a survivor care plan for
patients can be measured.
In the context of other chronic diseases, such as diabetes or
cardiac disease management, researchers have identified the
construct of patient activation, which is defined as the
knowledge, skill, and confidence of an individual to manage
their disease [16-19]. Based on this construct, Hibbard
developed a patient activation measure to document self-efficacy
regarding health behaviors, internal health locus of control, and
readiness for involvement in care [20,21]. A small study of a
technology-based symptom care plan for neurotoxicity during
cancer treatment showed a significant improvement in activation
from before to after use of the care plan [22,23], suggesting that
this outcome could be relevant after cancer treatment. Two other
randomized trials showed mixed results: no effect [13] and
increased activation after the survivor care plan visit [14].
Because a goal of the survivor care plan is to help survivors to
transition from a passive patient role to an active survivor role
and become more responsible for their own health care, it is
possible that this measure could more precisely document the
benefit of survivor care plan delivery.
To address the resource issues associated with the survivor care
plan, recent efforts have been made to use technology to
automate components of the survivor care plan. These efforts
reflect a broader trend to use technology as a means of
increasing quality of care and patient outcomes while decreasing
burden on health care professionals in both cancer care and
health care overall [24-26].
Another line of research has focused on the use of
technology-based survivor care plans for personalized survivor
care plan delivery. Researchers evaluated a prototype of a smart
phone application in a small sample of survivors and providers
in a hypothetical situation [27]. Both patients and providers
rated the prototype as usable, portable, and accessible. A
Web-based program was designed to generate a tailored survivor
care plan by incorporating input from the electronic health
record and directly from patients [28]. In a sample of 25 breast
cancer survivors, self-reported confidence was high before and
after receiving the survivor care plan; 70% were very satisfied
with it, and usability ratings were high. At least 75% of oncology
and primary care providers endorsed the program. Investigators
evaluated a technology-based platform with two components,
a symptom care plan and a survivor care plan, and found the
symptom care component to be feasible, usable, and acceptable
to breast cancer patients receiving neurotoxic chemotherapy
[22,23]. In contrast, a randomized study comparing two
Web-based survivor care plan tools (completed by the provider
versus the survivor) showed low completion rates by both groups
[29], suggesting that technology alone may not solve the
problem of survivor care plan implementation.
In summary, previous research provides some evidence that
self-reported survivor knowledge, confidence, and activation
may be sensitive to receipt of a survivor care plan, either paper
or electronic. However, further research is necessary to examine
survivor-reported outcomes and survivor experience associated
with use of a technology-based survivor care plan. In addition
to evaluating changes in survivor-reported outcomes during the
implementation of a technology-based survivor care plan, this
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research describes preferences for and satisfaction with the
technology and format in which the survivor care plan was
delivered.
The objectives of this pilot study were to: (1) examine
self-reported changes in knowledge, confidence, and activation
from before to after receipt of an electronically generated
survivor care plan by breast cancer survivors in an academic
cancer clinic and a community cancer clinic; and (2) describe
survivor preferences for and satisfaction with implementation
of an electronic survivor care plan.
Methods
Data Collection
The Institutional Review Board approved the research and each
participant provided informed consent. Eligible individuals were
required to: have pathologically confirmed breast cancer, stages
I-III; be over 18 years old; be completing a course of
chemotherapy; and be able to understand and read English.
Participants recruited from a National Cancer
Institute–designated comprehensive academic cancer center and
a community-based cancer center were enrolled at the follow-up
medical visit after completion of chemotherapy. The study used
a single-group pretest-posttest design. Participants completed
surveys both before (see Multimedia Appendix 1) and after (see
Multimedia Appendix 2) the medical visit and then one month
later (see Multimedia Appendix 3) to document changes in
knowledge, confidence, and activation as well as preference
for, and satisfaction with, the technology-based survivor care
plan.
The intervention consisted of a customized survivor care plan
that was developed and delivered via the Carevive Survivor
Care Planning system, a proprietary cloud-based system. This
system uses clinical data input into a proprietary rules engine
that automatically generates a draft care plan based on diagnosis,
treatment regimen, current clinical practice guidelines, and
nationally established quality metrics. The clinician can review,
edit, and customize the plan prior to sign off and delivery to the
survivor. The customized survivor care plan includes a treatment
summary as well as a care plan describing recommended
medical tests, appointments to schedule, and links to vetted
resources and reading materials about survivor health concerns
that are maintained and updated by the vendor. As a survivor’s
treatment and disease history progress, providers can input
additional information to the planning system and the survivor
care plan will be updated accordingly. This feature of the
Carevive system decreases the work required of providers in
creating survivor care plans. Rather than requiring providers to
continuously keep track of recommendations to survivors and
update them based on treatment progression, the Carevive
system allows them to simply transfer information on treatment
and disease progression from the electronic medical record into
the Carevive program interface, and then review and sign off
on the survivor care plan that is automatically generated. Ideally,
the survivor care plan document is delivered to the individual
electronically (via email or encrypted flash drive), thus enabling
full use of active links to information; however, the survivor
care plan document can also be printed and delivered in paper
form per the preference of the survivor. The most prominent
difference in features between the electronic and paper versions
of the survivor care plan is that the electronic version includes
embedded links that allow survivors to directly and immediately
access educational resources on their personal computers or
mobile devices. Within the Carevive platform, data are
maintained in a secure database with Health Insurance
Portability and Accountability Act–compliant standards of
privacy and security.
Survivor-Reported Outcomes
We evaluated knowledge and confidence with scales created
by the researchers to document changes in survivor-reported
knowledge of care expectations and confidence about
completing the necessary tasks related to the care plan. These
scales were used to distinguish knowledge or information
deficits and self-efficacy or skill-related gaps. Each scale
contained seven items rated on a 4-point scale from strongly
disagree to strongly agree. An example of a knowledge item
was: “I know which medical tests need to be done over the next
year and when to get them done.” A confidence item was: “I
am confident that I will get the medical tests done on time over
the next year.” Within each scale, items were summed, the total
score for each scale ranged from 7 to 28, and higher scores
indicated higher knowledge or confidence.
We also measured self-reported survivor activation. The
activation survey is a 13-item scale measuring the degree to
which individuals feel prepared to actively participate in
self-management [20,21]. Items are measured on a 4-point Likert
scale with a range of strongly agree to strongly disagree. Total
raw scores ranged from 13-52 (lowest to highest activation).
Psychometric evaluation in previous research has revealed strong
reliability and validity [20]. In groups with chronic illnesses,
higher activation scores predicted higher likelihoods of
engagement in preventive health behaviors, of seeking out health
information, of performing regular self-monitoring at home,
and of lower health care utilization [17,19,30]. In addition to
being a measurable construct, activation can be influenced by
interventions, such as delivery of a survivor care plan, that focus
on providing information and resources to guide action [30,31].
Survivor Preference and Satisfaction
We examined survivor preferences for the fully functional
electronic format of the survivor care plan with or without a
paper document versus the paper document alone. We asked
participants to rate their satisfaction with the chosen format on
a 4-point scale from strongly agree to strongly disagree, as well
as to rate the acceptability of the content (ie, ease of
understanding, helpfulness of the information and resources,
satisfaction with the experience, and recommendation to others)
on a separate 4-point scale from strongly agree to strongly
disagree.
Statistical Analysis
Demographic characteristics of the subjects were summarized
by means and SDs or counts and percentages, as appropriate,
stratifying by site (academic or community center). We assessed
differences between the sites with two-tailed t tests and Fisher’s
exact test.
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To evaluate the changes in the survivor-reported outcomes, we
fit linear mixed models using the MIXED Procedure (PROC
MIXED) in SAS 9.4 (SAS Institute Inc, Cary, North Carolina).
Fixed effects included site, time point, and a site by time point
interaction; a random intercept was allowed for each subject.
We considered several possible correlation structures to account
for the repeated measures within subject, including unstructured,
compound symmetry, and first-order autoregressive, with the
final selection, compound symmetry, based on Akaike
Information Criterion. Boxplots display the distribution of
knowledge, confidence, and activation scores for the subjects
at each time point and site. We also used Fisher’s exact test to
evaluate the association between preferred survivor care plan
format and available demographics characteristics. For all
analyses, Cronbach alpha=.05.
Results
Demographics
A total of 38 breast cancer survivors agreed to participate in the
study, 15 in the academic center and 23 in the community center
group (Table 1). The sample was primarily non-Hispanic white
and married or partnered, and about half had at least some
college education. Overall, 7/15 academic center participants
(46%) and 8/23 community center participants (30%) were
working at the time of the study.
Table 1. Demographic characteristics by clinical setting.
P valueCommunity Center (n=23)Academic Center (n=15)Demographics
.2252.3 (12.8)57.6 (12.8)Age, mean (SD)
.64Race, n (%)
3 (13)4 (27)African American
19 (83)11 (73)Caucasian
1 (4)0 (0)Other
.14Ethnicity, n (%)
19 (83)15 (100)Non-Hispanic
4 (17)0 (0)Hispanic
.88Marital Status, n (%)
2 (9)2 (13)Single
17 (74)10 (67)Married or partnered
4 (17)3 (20)Divorced, separated, widowed
.08Education, n (%)
11 (48)3 (20)High school, vocational/technical
11 (48)8 (53)College (Associates/Bachelors)
1 (4)4 (27)Advanced degree
.76Employment, n (%)
8 (35)7 (47)Work full/part-time
1 (4)0 (0)Unemployed
8 (35)4 (27)Retired
4 (17)4 (27)Disabled
2 (9)0 (0)Homemaker
Survivor-Reported Outcomes
Participants at both sites reported significant increases in
knowledge from baseline to immediately after receipt of the
survivor care plan and 1 month later (Table 2). At baseline, the
community center group had lower knowledge levels than the
academic center group (mean difference 2.5; 95% CI 0.0-4.9;
P=.05). Knowledge was similar between the sites immediately
post–survivor care plan and 1 month later (Figure 1). Baseline
confidence was also slightly lower in the community center
compared to the academic center group (mean difference 2.0;
95% CI 0.1-4.0; P=.04) (Table 2). Confidence scores of the
community center group increased from baseline to immediately
and 1-month post–survivor care plan, and confidence levels of
the academic center group did not significantly change (Figure
2). Like knowledge and confidence, community center
participants had lower levels of activation at baseline compared
to the academic center (mean difference 3.9; 95% CI 0.3-7.5;
P=.04) (Table 2). The activation score improved for the
community center participants at the immediate, post, and
1-month time points relative to baseline. Academic center
participants saw modest improvement at the immediately
post–survivor care plan time point (change=2.2; 95% CI 0.0-4.5;
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P=.05), but the 1-month activation scores were not significantly different from baseline (Figure 3).
Table 2. Model-estimated least squares means for knowledge, confidence, and activation over time for each setting.
P valueDifference mean (95% CI)Community center mean (95% CI)Academic center mean (95% CI)Categories
Knowledge
.052.5 (0.0-4.9)16.3 (14.7-17.8)18.7 (16.8-20.7)Pre-SCPa
.73–0.4 (–3.0 to 2.1)23.3 (21.7-24.9)22.8 (20.8-24.8)Post-SCP
.910.2 (–2.4 to 2.7)22.1 (20.6-23.7)22.3 (20.3-24.3)1 month post-SCP
—
—
b7.0 (5.3-8.7)4.1 (2.0-6.2)Change from pre to post
——<.001<.001P value
——5.9 (4.2-7.6)3.6 (1.4)Change from pre to 1 month
——<.001.002P value
Confidence
.042.0 (0.1-4.0)21.6 (20.3-22.8)23.6 (22.1-25.1)Pre-SCP
.510.7 (–1.3 to 2.6)23.3 (22.1-24.5)24.0 (22.4-25.5)Post-SCP
.800.3 (–1.8 to 2.3)23.7 (22.5-24.9)24.0 (22.4-25.6)1 month post-SCP
——1.7 (0.6-2.9)0.4 (–1.1 to 1.8)Change from pre to post
———.63P value
——2.1 (1.0-3.3)0.4 (–1.1 to 1.9)Change from pre to 1 month
———.63P value
Activation
.043.9 (0.3-7.5)38.7 (36.5-41.0)42.6 (39.8-45.4)Pre-SCP
.371.6 (–2.0 to 5.3)43.2 (40.9-45.4)44.8 (42.0-47.7)Post-SCP
.910.2 (–3.5 to 3.9)43.1 (40.8-45.3)43.3 (40.4-46.2)1 month post-SCP
——4.4 (2.7-6.2)2.2 (0.0-4.5)Change from pre to post
——<.001.05P value
——4.3 (2.5-6.1)0.7 (–1.7 to 3.1)Change from pre to 1 month
——<.001.56P value
aSCP: survivor care plan.
bNot applicable.
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Figure 1. Knowledge levels of study participants before, immediately after, and one-month after SCP presentation. At baseline, the community center
group had lower knowledge levels than the academic center group. Knowledge was similar between the sites immediately post-SCP and 1 month later.
SCP: survivor care plan.
Figure 2. Confidence level before, immediately after, and one-month after SCP presentation. Confidence at baseline was slightly lower in the community
center compared to the academic center. Confidence scores of the community center group increased from baseline to immediately and one month
post-SCP; confidence levels of the academic center group did not significantly change. SCP: survivor care plan.
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Figure 3. Activation levels before, immediately after, and one month after SCP presentation. Community center participants had lower levels of
activation at baseline compared to the academic center. Activation score improved for community center participants at the immediate post and one-month
time points relative to baseline. Academic center participants saw modest improvement at the immediately post time point, but the one-month activation
scores were not significantly different from baseline. SCP: survivor care plan.
Survivor Preference and Satisfaction
Overall, 22/38 (58%) of participants chose the fully functional
electronic survivor care plan with or without a paper version
(Table 3). It is noteworthy that 12 (52%) of the community
center participants requested the paper version of the survivor
care plan in comparison to 4 (27%) of the academic center
participants. Survivor care plan format preference did not differ
between sites with regard to age (P=.51), employment status
(working versus not working, P=.86), or education (high school
versus college, P=.83) (see Multimedia Appendix 4). All
participants were satisfied with their chosen survivor care plan
format, and almost all participants at both sites, regardless of
chosen format, found the survivor care plan to be easy to
understand, with useful information and resources. All but one
participant agreed or strongly agreed that the experience was
positive and that they would recommend the survivor care plan
to other survivors.
Table 3.  Preference for and acceptability of technology-based survivor care plan by clinical setting.
P valueCommunity center (n=23), n (%)Academic center (n=15), n (%)Categories
.16  SCP format
1 (4)3 (20)Flash drive
12 (52)4 (27)Paper document
10 (43)8 (53)Both flash drive and paper document
.74  Format useful
13 (57)7 (47)Agree
10 (43)8 (53)Strongly agree
.66  Overall experience
0 (0)1 (7)Negative
5 (22)3 (20)Positive
18 (78)11 (73)Very positive
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Discussion
The results of our examination of the efficacy of the survivor
care plan show that participants reported positive changes in
knowledge, confidence, and activation from before to after using
the technology-based survivor care plan; this suggests that use
of the survivor care plan could be responsible for these changes.
While the positive change cannot be attributed definitively to
the implementation of the survivor care plan, it suggests the
need for a randomized controlled trial to test this hypothesis.
We noted that the confidence scores of the community center
group increased from baseline to both subsequent time points,
while the confidence levels of the academic center group did
not significantly change. Community center activation scores
were also improved at the immediately post–survivor care plan
receipt time point as well as 1 month later, while activation
scores at the academic center improved only modestly at the
time point immediately post–survivor care plan receipt and at
the 1-month time point were not significantly different from
baseline. The differences in confidence and activation between
the academic and community settings are difficult to explain.
Previous clinical trials evaluating survivor-level outcomes found
no effect of survivor care plans on quality of life, mood
disturbances, or satisfaction with care [6-8]. This research has
identified alternative patient-reported outcomes that may more
appropriately capture the variables likely to be influenced by a
survivor care plan. Knowledge and confidence have both been
identified in many theories as psychological variables that are
likely to be involved in behavioral change [32-34]. Activation
has also been identified in research on self-management of
chronic diseases as an important indicator of readiness to take
an active participatory role in one’s health care [17]. Thus,
despite a relatively small sample size, the fact that our
exploratory study found positive changes in all three of these
measures after survivor care plan implementation suggests that
survivors may benefit from survivor care plan use, and also
invites further investigation of survivor care plan efficacy.
The second goal of this research was to examine uptake of the
fully functional electronic version of the survivor care plan
versus the paper document only. In this sample, 22/38 (58%)
participants chose the electronic survivor care plan, either by
itself or in addition to the paper survivor care plan. A total of
34/38 (89%) participants chose the paper format, either by itself
or in addition to the electronic survivor care plan. However,
only 4/38 (11%) participants elected to receive just the flash
drive, compared to 16 (42%) who elected to receive only paper.
It could be argued that technology is not fully functional until
a substantial majority choose the technology-based option. A
platform that functions exclusively electronically thus runs the
risk of leaving behind patients who lack the skills to access it
and deepening disparities that affect cancer patients and
survivors.
Another feature of this study was the comparison between an
academic and a community setting. Although we noted
differences in survivor care plan format preference by treatment
setting, the difference could not be attributed to age, education,
or work status differences. However, we did not include any
indicators of technological aptitude or savviness that could
further explain the difference, such as frequency of interaction
with an electronic interface or use of a smartphone. Regarding
survivor care plan acceptability, our research agrees with past
studies showing that cancer survivors have generally found
technology-based survivor care plans acceptable [22,27,28].
Future research should evaluate the influence of technology
literacy and aptitude on the choice of survivor care plan format
in different clinical settings.
Our study sought to shed light on the potential for this novel
electronic platform as a means of generating and delivering
survivor care plans to breast cancer survivors. The fact that the
survivor care plan examined in our study was offered in two
formats strengthened our examination of survivor care plan
efficacy by maximizing accessibility to participants. However,
because the participants were offered the option of receiving
their survivor care plan in both electronic and paper formats it
limited our ability to draw conclusions regarding the electronic
format, thus ultimately acting as a double-edged sword.
Participants who selected both options were not queried about
which of the formats they used, and their satisfaction with and
perceived benefit from that format.
This pilot study had several additional limitations. First, it was
not a randomized controlled trial, so the results are
hypothesis-generating and not generalizable. Second, the sample
size was small. A third limitation of this research was its lack
of focus on clinician perceptions of this technology-based
survivor care plan. A more robust evaluation of this intervention
would require that all these limitations be addressed.
This research has contributed to the developing body of
knowledge about the implementation of technology-based
survivor care plans. The identification of patient-reported
outcomes that are likely to be influenced by a survivor care plan
intervention has been a barrier to success in previous research.
It is possible that the outcomes measured in this research
(knowledge, confidence, and activation) could be more
appropriate indicators of efficacy for paper- or technology-based
survivor care plans. Cancer survivors have attested to the
acceptability of survivor care plans; however, challenges remain
in fully implementing technology-based survivor care plans.
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Multimedia Appendix 4
Supplemental Table 1: SCP format selection.
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